ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) (TSX.V:IPA) Reports C$4.8M Revenue in Q3
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) (TSX.V:IPA) stock has been trending higher this week after the company reported Q3 earnings on March 16. For the latest quarter, the company reported total revenue of C$4.8 million, an 6.6% growth year-over-year of C$4.5 million.… Continue Reading